Trial intelligence / Profile preview

Deep vs Standard Neuromuscular Blockade in Open Upper Abdominal Surgery

NCT02140593Phase 4Completed

Sponsor
Herlev Hospital
Start
Sep 2014
Primary completion
May 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of rocuronium in gastrointestinal cancer, sponsored by Herlev Hospital. Started Sep 2014; status: completed.

02

Drugs

rocuronium
03

Conditions

gastrointestinal cancer

Beyond the preview

Go deeper on NCT02140593.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02140593.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call